FindTrial
Sign In

Application of 16SRNA sequencing to evaluate wuqinxi in improving prognosis of Parkinson's disease

Application of 16SRNA sequencing to evaluate wuqinxi in improving prognosis of Parkinson's disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016550
Enrollment
Unknown
Registered
2018-06-07
Start date
2018-06-07
Completion date
Unknown
Last updated
2018-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Interventions

all subjects:Wuqinxi intervention

Sponsors

101th Hospital of PLA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The proportion of age, sex and weight of PD patients in group was best matched.

Exclusion criteria

Exclusion criteria: Patients who were unable to complete sampling and the participants who researchers considered inappropriate.

Design outcomes

Primary

MeasureTime frame
bacterial goup;Balance control ability, gait, muscle strength, timing rise, number of falls, and walking test scores;UPDRS III score;fMRI;PET-CT;—

Countries

China

Contacts

Public ContactLin Wei

101th Hospital of PLA

smithlinwx@aliyun.com+86 13812512187

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026